{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:45:01Z","timestamp":1682613901850},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"783","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991,1,1]]},"DOI":"10.1136\/pgmj.67.783.23","type":"journal-article","created":{"date-parts":[[2008,12,29]],"date-time":"2008-12-29T21:01:03Z","timestamp":1230584463000},"page":"23-32","source":"Crossref","is-referenced-by-count":1,"title":["Endocrinology"],"prefix":"10.1093","volume":"67","author":[{"given":"M A","family":"Baxter","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Birmingham, Queen Elizabeth Hospital , Edgbaston, Birmingham B15 2TH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Sheppard","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Birmingham, Queen Elizabeth Hospital , Edgbaston, Birmingham B15 2TH, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1991,1,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/jcem-70-6-1518","article-title":"Current trends in the management of Graves' disease","volume":"70","year":"1990","unstructured":"Current trends in the management of Graves' disease. J. Clin Endocrinol Metab 1990, 70: 1518-1524.","journal-title":"J. Clin Endocrinol Metab"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(89)90288-2","article-title":"Radioiodine and aggravation of Graves'","volume":"i:","author":"Vestergaard, H.; Laurberg, P.","year":"1989","unstructured":"Vestergaard, H. & Laurberg, P. Radioiodine and aggravation of Graves' ophthalmopathy. Lancet 1989, i: 47.","journal-title":"ophthalmopathy. Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1001\/jama.1982.03320400047033","article-title":"Effect on exophthalmos of various methods of treatment of Graves'","volume":"247","author":"Gwinup, G.; Elias, A.N.; Ascher, M.S.","year":"1982","unstructured":"Gwinup, G., Elias, A.N. & Ascher, M.S. Effect on exophthalmos of various methods of treatment of Graves' disease. JAMA 1982, 247: 2135-2138.","journal-title":"disease. JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9343(89)80485-1","article-title":"Treatment of Graves' disease and the course of ophthalmopathy","volume":"87","author":"Sridama, V.; DeGroot, L.J.","year":"1989","unstructured":"Sridama, V. & DeGroot, L.J. Treatment of Graves' disease and the course of ophthalmopathy. Am J Med 1989, 87: 70-73.","journal-title":"Am J Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM198911163212001","article-title":"Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism","volume":"321","author":"Bartalena, L.; Marcocci, C.; Bogazzi, F.; Panicucci, M.; Lepri, A.; Pinchera, A.","year":"1989","unstructured":"Bartalena, L., Marcocci, C., Bogazzi, F., Panicucci, M., Lepri, A. & Pinchera, A. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989, 321: 1349-1352.","journal-title":"N Engl J Med"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/bmj.300.6736.1352","article-title":"Graves'","volume":"300","author":"Fleck, B.W.; Toft, A.D.","year":"1990","unstructured":"Fleck, B.W. & Toft, A.D. Graves' ophthalmopathy. Br MedJ 1990, 300: 1352-1353.","journal-title":"ophthalmopathy. Br MedJ"},{"key":"ref_7","first-page":"297","article-title":"Intravenous methylprednisolone in the treatment of Graves'","volume":"1988","author":"Kendall-Taylor, P.; Crombie, A.L.; Stephenson, A.; Hardwick, M.& Hall; K.","unstructured":"Kendall-Taylor, P., Crombie, A.L., Stephenson, A., Hardwick, M.& Hall, K. Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy. Br Med J 1988, 297: 1574-1578.","journal-title":"ophthalmopathy. Br Med J"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJM198911163212009","article-title":"Treatment of Graves' ophthalmopathy","volume":"321","author":"Utiger, R.D.","year":"1989","unstructured":"Utiger, R.D. Treatment of Graves' ophthalmopathy. N Engl J Med 1989, 321: 1403-1405.","journal-title":"N Engl J Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","article-title":"Prednisone and cyclosporine in the treatment of severe Graves'","volume":"321","author":"Prummel, M.F.; Mourits, M.P.; Berghout, A.","year":"1989","unstructured":"Prummel, M.F., Mourits, M.P., Berghout, A. et al. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. N Engl J Med 1989, 321: 1353-1359.","journal-title":"ophthalmopathy. N Engl J Med"},{"key":"ref_10","first-page":"\"1261","article-title":"Association between Graves' ophthalmopathy and smoking","volume":"335","author":"Shine, B.; Fells, P.; Edwards, O.M.; Weetman, A.P.","year":"1990","unstructured":"Shine, B., Fells, P., Edwards, O.M. & Weetman, A.P. Association between Graves' ophthalmopathy and smoking. Lancet 1990, 335: 1261-1263. Bacharach, P. The aging thyroid. The use of thyroid hormone in older persons. JAMA 1989, 261: 2653-2655.","journal-title":"Lancet; The aging thyroid. The use of thyroid hormone in older persons"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0002-9343(87)90219-1","article-title":"Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitarythyroid axis with L-thyroxine","volume":"82","author":"Ross, D.S.; Neer, R.M.; Ridgway, E.C.; Daniels, G.H.","year":"1987","unstructured":"Ross, D.S., Neer, R.M., Ridgway, E.C. & Daniels, G.H. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitarythyroid axis with L-thyroxine. Am J Med 1987, 82: 1167-1170.","journal-title":"Am J Med"},{"issue":"259","key":"ref_12","first-page":"3137","article-title":"Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women","volume":"1988","author":"Paul, T.L.; Kerrigan, J.; Kelly, A.M.; Braverman, L.E.; Baran, D.T.","unstructured":"Paul, T.L., Kerrigan, J., Kelly, A.M., Braverman, L.E. & Baran, D.T. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988, 259: 3137-3141.","journal-title":"JAMA"},{"issue":"259","key":"ref_13","first-page":"3175","article-title":"Thyroid hormone and the skeleton: a bone of contention","volume":"1988","author":"Cooper, D.S.","unstructured":"Cooper, D.S. Thyroid hormone and the skeleton: a bone of contention. JAMA 1988, 259: 3175.","journal-title":"JAMA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1990.tb00471.x","article-title":"Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone","volume":"33","author":"Taelman, P.; Kaufman, J.M.; Janssens, X.; Vandecauter, H.; Vermeulen, A.","year":"1990","unstructured":"Taelman, P., Kaufman, J.M., Janssens, X., Vandecauter, H. & Vermeulen, A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol 1990, 33: 107-117.","journal-title":"Clin Endocrinol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1365-2265.1990.tb00477.x","article-title":"Bone mineral density and thyroid hormone therapy","volume":"33","author":"Ribot, C.; Tremollieres, F.; Pouilles, J.M.; Louvet, J.P.","year":"1990","unstructured":"Ribot, C., Tremollieres, F., Pouilles, J.M. & Louvet, J.P. Bone mineral density and thyroid hormone therapy. Clin Endocrinol 1990, 33: 143-153.","journal-title":"Clin Endocrinol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/jbmr.5650050507","article-title":"Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study","volume":"5","author":"Toh, S.H.; Brown, P.H.","year":"1990","unstructured":"Toh, S.H. & Brown, P.H. Bone mineral content in hypothyroid male patients with hormone replacement: a 3-year study. J Bone Min Res 1990, 5: 463-467.","journal-title":"J Bone Min Res"},{"key":"ref_17","article-title":"Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1990, in press","author":"Parle, J.V.; Franklyn, J.A.; Cross, K.W.; Jones, S.C.; Sheppard, M.C.","unstructured":"Parle, J.V., Franklyn, J.A., Cross, K.W., Jones, S.C. & Sheppard, M.C. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol 1990, in press."},{"key":"ref_18","first-page":"\"693","article-title":"Thyroxine replacement treatment and osteoporosis","volume":"300","author":"Franklyn, J.A.; Sheppard, M.C.","year":"1990","unstructured":"Franklyn, J.A. & Sheppard, M.C. Thyroxine replacement treatment and osteoporosis. Br Med J 1990, 300: 693-694. Same, D.H., Sobieszczyk, S., Ain, K. & Refetoff, S. Serum thyrotrophin and prolactin in the syndrome of generalised resistance to thyroid hormone: responses to thyrotropinreleasing horomone stimulation and short term triiodothyronine suppression. J Clin Endocrinol Metab 1990, 70, 1305-1311.","journal-title":"Br Med J; Serum thyrotrophin and prolactin in the syndrome of generalised resistance to thyroid hormone: responses to thyrotropinreleasing horomone stimulation and short term triiodothyronine suppression"},{"issue":"29","key":"ref_19","first-page":"337","article-title":"Hormonal control of gene expression","volume":"1988","author":"Franklyn, J.A.; Sheppard, M.C.","unstructured":"Franklyn, J.A. & Sheppard, M.C. Hormonal control of gene expression. Clin Endocrinol 1988, 29: 337-348.","journal-title":"Clin Endocrinol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0950-351X(88)80023-5","article-title":"Mechanisms of thyroid hormone action","volume":"2","author":"Franklyn, J.A.","year":"1989","unstructured":"Franklyn, J.A. Mechanisms of thyroid hormone action. In: Sheppard, M.C. (ed.) Molecular Endocrinology. Ballieres Clinical Endocrinology and Metabolism, vol. 2. Bailliere Tindall, London, 1989, pp. 891-909.","journal-title":"Ballieres Clinical Endocrinology and Metabolism; Molecular Endocrinology"},{"key":"ref_21","first-page":"2","article-title":"Tight linkage between the syndrome of generalised thyroid hormone resistance and the human c-erb A P gene","volume":"1988","author":"Usala, S.J.; Bale, A.E.; Gesundheit, N.","unstructured":"Usala, S.J., Bale, A.E., Gesundheit, N. et al. Tight linkage between the syndrome of generalised thyroid hormone resistance and the human c-erb A P gene. Mol Endocrinol 1988, 2: 1217-1220.","journal-title":"Mol Endocrinol"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1172\/JCI114438","article-title":"A base mutation of the c-erb A P thyroid hormone receptor in a kindred with generalised thyroid hormone resistance","volume":"85","author":"Usala, S.J.; Tennyson, G.E.; Bale, A.E.","year":"1990","unstructured":"Usala, S.J., Tennyson, G.E., Bale, A.E. et al. A base mutation of the c-erb A P thyroid hormone receptor in a kindred with generalised thyroid hormone resistance. J Clin Invest 1990, 85, 93-100.","journal-title":"J Clin Invest"},{"key":"ref_23","series-title":"Proceedings of the 72nd Annual Meeting of the American Endocrine Society; Generalised resistance to thyroid hormone associated with a mutation in the ligand binding domain","first-page":"26","article-title":"Generalised thyroid hormone resistance: clinical and molecular studies","volume":"14","author":"Usala, S.J.; Wondisford, F.E.; Watson, T.L.","year":"1990","unstructured":"Usala, S.J., Wondisford, F.E., Watson, T.L. et al. Generalised thyroid hormone resistance: clinical and molecular studies. Proceedings of the 72nd Annual Meeting of the American Endocrine Society 1990, Atlanta, 14A. 26. Sakurai, A., Takeda, K., Ain, K. et al. Generalised resistance to thyroid hormone associated with a mutation in the ligand binding domain of the human thyroid hormone receptor P. Proc Natl Acad Sci USA 1989, 86: 8977-8981."},{"key":"ref_24","first-page":"659","article-title":"Screening of 19 unrelated families with generalised resistance to thyroid hormone for known point mutations in the thyroid receptor P and the detection of a new mutation","volume":"3","author":"Takeda, K.; Balzano, S.; Sakurai, A.; DeGroot, L.; Refetoff, S.","year":"1990","unstructured":"Takeda, K., Balzano, S., Sakurai, A., DeGroot, L. & Refetoff, S. Screening of 19 unrelated families with generalised resistance to thyroid hormone for known point mutations in the thyroid receptor P and the detection of a new mutation. Proceedings of the 72nd Annual Meeting of the American Endocrine Society 1990, Atlanta, 3A. 28. Koenig, R.J., Lazar, M.A., Hodin, R.A. et al. Inhibition of thyroid hormone action by a non-hormone binding c-erb A protein generated by alternate mRNA splicing. Nature 1989, 337: 659-661.","journal-title":"Proceedings of the 72nd Annual Meeting of the American Endocrine Society; Nature; Inhibition of thyroid hormone action by a non-hormone binding c-erb A protein generated by alternate mRNA splicing"},{"issue":"65","key":"ref_25","first-page":"579","article-title":"Body composition response to exogenous GH during training in highly conditioned adults","volume":"1988","author":"Crist, D.M.; Peake, G.T.; Egan, P.A.; Waters, D.L.","unstructured":"Crist, D.M., Peake, G.T., Egan, P.A. & Waters, D.L. Body composition response to exogenous GH during training in highly conditioned adults. J Appl Physiol 1988, 65: 579-584.","journal-title":"J Appl Physiol"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon, F.; Cuneo, R.C.; Hesp, R.; Sonksen, P.","year":"1989","unstructured":"Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989, 321: 1797-1803.","journal-title":"N Engl J Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GHdeficient adults","volume":"i:","author":"Jorgensen, J.O.L.; Pedersen, S.A.; Thuesen, L.","year":"1989","unstructured":"Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L. et al. Beneficial effects of growth hormone treatment in GHdeficient adults. Lancet 1989, i: 1221-1224.","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199007053230101","article-title":"Effects of human growth hormone in men over 60 years old","volume":"323","author":"Rudman, D.; Feller, A.G.; Nagraj, H.S.","year":"1990","unstructured":"Rudman, D., Feller, A.G., Nagraj, H.S. et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990, 323: 1-5.","journal-title":"N Engl J Med"},{"key":"ref_29","first-page":"\"52","article-title":"Growth hormone for the elderly","volume":"323","author":"Vance, M.L.","year":"1990","unstructured":"Vance, M.L. Growth hormone for the elderly. N Engl J Med 1990, 323: 52-53. Rosenfeld, R.G. Update on growth hormone therapy for Turner's syndrome. Acta Paediatr Scand (Suppl) 1989, 356: 103-108.","journal-title":"N Engl J Med; Update on growth hormone therapy for Turner's syndrome"},{"issue":"113","key":"ref_30","first-page":"393","article-title":"Three year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner's syndrome","volume":"1988","author":"Rosenfeld, R.G.; Hantz., R.L.; Johanson, A.J.","unstructured":"Rosenfeld, R.G., Hantz., R.L., Johanson, A.J. et al. Three year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner's syndrome. J Pediatr 1988, 113: 393-400.","journal-title":"J Pediatr"},{"issue":"349","key":"ref_31","first-page":"158","article-title":"and the Belgian Study Group for Paediatric Endocrinology. The Belgian genotropin Turner trial: preliminary results","volume":"1989","author":"Vandersschueren-Lodeweyckx, M.; Massa, G.; Maes, M.","unstructured":"Vandersschueren-Lodeweyckx, M., Massa, G., Maes, M. and the Belgian Study Group for Paediatric Endocrinology. The Belgian genotropin Turner trial: preliminary results. Acta Paediatr Scand (Suppl) 1989, 349: 158. Homburg, R., Eshel-A, Abdalla, H.I. & Jacobs, H.S. Growth hormone facilities ovulation induction by gonadotrophins. Clin Endocrinol 1988, 29: 113-117.","journal-title":"Acta Paediatr Scand (Suppl); Growth hormone facilities ovulation induction by gonadotrophins"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0015-0282(16)53277-4","article-title":"Cotreatment with human growth hormone and gonadotrophins for induction ofovulation: a controlled clinical trial","volume":"53","author":"Homberg, R.; West-C, Tornsani; T.; Jacobs, H.-S.","year":"1990","unstructured":"Homberg, R., West-C, Tornsani, T. & Jacobs, H.-S. Cotreatment with human growth hormone and gonadotrophins for induction ofovulation: a controlled clinical trial. Fertil-Steril 1990, 53: 254-260.","journal-title":"Fertil-Steril"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"\"345","DOI":"10.1093\/oxfordjournals.humrep.a137102","article-title":"Pregnancy following combined growth hormone - pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea","volume":"5","author":"Volpe, A.; Goukos, G.; Artini, P.G.","year":"1990","unstructured":"Volpe, A., Goukos, G., Artini, P.G. et al. Pregnancy following combined growth hormone - pulsatile GnRH treatment in a patient with hypothalamic amenorrhoea. Hum Reprod 1990, 5: 345-347. Broadus, A.E., Mangin, M., Ikeda, K. et al. Humoral hypercalcaemia of cancer: Identification of a novel parathyroid hormone like peptide. N Engi J Med 1988, 319: 356-363.","journal-title":"Hum Reprod; Humoral hypercalcaemia of cancer: Identification of a novel parathyroid hormone like peptide"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0140-6736(90)90537-F","article-title":"Parathyroid-hormone-related protein in tumours associated with hypercalcaemia","volume":"335","author":"Heath, D.A.; Senior, P.V.; Varley, J.M.; Beck, F.","year":"1990","unstructured":"Heath, D.A., Senior, P.V., Varley, J.M. & Beck, F. Parathyroid-hormone-related protein in tumours associated with hypercalcaemia. Lancet 1990, 335: 66-68.","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0140-6736(89)91791-1","article-title":"Comparison of three bisphosphonates in cancer associated hypercalcaemia","volume":"i:","author":"Ralston, S.H.; Gallacher, S.J.; Patel, V.","year":"1989","unstructured":"Ralston, S.H., Gallacher, S.J., Patel, V. et al. Comparison of three bisphosphonates in cancer associated hypercalcaemia. Lancet 1989, i: 1180-1182.","journal-title":"Lancet"},{"key":"ref_36","first-page":"\"1930","article-title":"Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures ofhuman bone marrow","volume":"83","author":"Hughes, D.E.; McDonald, B.R.; Russell, R.C.G.; Gowen, M.","year":"1989","unstructured":"Hughes, D.E., McDonald, B.R., Russell, R.C.G. & Gowen, M. Inhibition of osteoclast-like cell formation by bisphosphonates in long term cultures ofhuman bone marrow. J Clin Invest 1989, 83: 1930-1935. Riggs, B.L. A new option for treating osteoporosis. N Engi J Med 1990, 323: 124-125.","journal-title":"J Clin Invest; A new option for treating osteoporosis"},{"key":"ref_37","first-page":"523","article-title":"Bisphosphonates - history and experimental basis","volume":"8","author":"Fleisch, H.","year":"1987","unstructured":"Fleisch, H. Bisphosphonates - history and experimental basis. Bone 1987, 8 (Suppl): 523-528.","journal-title":"Bone"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of post menopausal osteoporosis","volume":"323","author":"Watts, N.B.; Steven, M.D.; Harris, S.T.","year":"1990","unstructured":"Watts, N.B., Steven, M.D., Harris, S.T. et al. Intermittent cyclical etidronate treatment of post menopausal osteoporosis. N Engi J Med 1990, 323: 73-79.","journal-title":"N Engi J Med"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","article-title":"Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis","volume":"322","author":"Storm, T.; Thamsborg, G.; Steinichet, T.; Genant, H.K.; Sorensen, H.O.","year":"1990","unstructured":"Storm, T., Thamsborg, G., Steinichet, T., Genant, H.K. & Sorensen, H.O. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990, 322: 1265-1271.","journal-title":"N Engl J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/67\/783\/23\/50075279\/postgradmedj-67-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/67\/783\/23\/50075279\/postgradmedj-67-23.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:17:57Z","timestamp":1682612277000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/67\/783\/23\/7061570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1,1]]},"references-count":39,"journal-issue":{"issue":"783","published-online":{"date-parts":[[1991,1,1]]},"published-print":{"date-parts":[[1991,1,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.67.783.23","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1991,1]]},"published":{"date-parts":[[1991,1,1]]}}}